Xtl Biopharmaceuticals (XTLB) Assets (2009 - 2025)
Xtl Biopharmaceuticals' Assets came in at $166,000 for the quarter ended Dec 31, 2025, down 98.1% from $8.55 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Assets (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Assets data covers 66 quarters.
- Assets carries a five-year compound annual growth rate of -52.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Assets was $8.55 million in the year ended Dec 31, 2024 (+252.4%), $2.43 million in the year ended Dec 31, 2023 (-42.0%), $4.19 million in the year ended Dec 31, 2022 (-36.7%) and $6.62 million in the year ended Dec 31, 2021 (+1.8%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Assets in data going back to the quarter ended Mar 31, 2009.
- Year-over-year, Assets increased in two of the last six quarters, with growth averaging 50.7%.
- The fastest year-over-year change in Assets over five years came in the quarter ended Dec 31, 2024 (growth of 252.4%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 98.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | 166,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Dec 31, 2024 | 8.55 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 6.62 Mn |
| Dec 31, 2021 | 6.62 Mn |
| Sep 30, 2021 | 6.86 Mn |
| Jun 30, 2021 | 6.95 Mn |
| Mar 31, 2021 | 7.31 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 6.21 Mn |
API Access
Xtl Biopharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();